Keros Therapeutics, Inc. — 10-Q Filings
18 10-Q filings on record
This page lists all 10-Q filings submitted to the SEC by Keros Therapeutics, Inc. (KROS), sorted by most recent first. Each row links to the full filing on EdgarLookup. Keros Therapeutics, Inc. has filed 18 10-Q documents with the SEC since 2016. To view all SEC filings by Keros Therapeutics, Inc., see the full filings list.
All
10-K
10-Q
144
3
3/A
4
4/A
424B4
424B5
8-A12B
8-K
8-K/A
ARS
CERT
CORRESP
D
D/A
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
POS EX
S-1
S-1/A
S-1MEF
S-3ASR
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SC TO-C
SC TO-I
SC TO-I/A
SCHEDULE 13D
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 10-Q | 10-Q | 0001664710-25-000089 | Nov 5, 2025 | Sep 30, 2025 |
| 10-Q | 10-Q | 0001664710-25-000070 | Aug 6, 2025 | Jun 30, 2025 |
| 10-Q | 10-Q | 0001664710-25-000046 | May 6, 2025 | Mar 31, 2025 |
| 10-Q | 10-Q | 0001664710-24-000091 | Nov 6, 2024 | Sep 30, 2024 |
| 10-Q | 10-Q | 0001664710-24-000068 | Aug 7, 2024 | Jun 30, 2024 |
| 10-Q | 10-Q | 0001664710-24-000039 | May 8, 2024 | Mar 31, 2024 |
| 10-Q | 10-Q | 0001664710-23-000066 | Nov 6, 2023 | Sep 30, 2023 |
| 10-Q | 10-Q | 0001664710-23-000050 | Aug 7, 2023 | Jun 30, 2023 |
| 10-Q | 10-Q | 0001664710-23-000030 | May 4, 2023 | Mar 31, 2023 |
| 10-Q | 10-Q | 0001664710-22-000056 | Nov 3, 2022 | Sep 30, 2022 |
| 10-Q | 10-Q | 0001664710-22-000040 | Aug 4, 2022 | Jun 30, 2022 |
| 10-Q | 10-Q | 0001664710-22-000019 | May 5, 2022 | Mar 31, 2022 |
| 10-Q | 10-Q | 0001664710-21-000065 | Nov 4, 2021 | Sep 30, 2021 |
| 10-Q | 10-Q | 0001664710-21-000053 | Aug 5, 2021 | Jun 30, 2021 |
| 10-Q | 10-Q | 0001664710-21-000025 | May 6, 2021 | Mar 31, 2021 |
| 10-Q | 10-Q | 0001664710-20-000050 | Nov 10, 2020 | Sep 30, 2020 |
| 10-Q | 10-Q | 0001664710-20-000027 | Aug 13, 2020 | Jun 30, 2020 |
| 10-Q | 10-Q | 0001664710-20-000006 | May 22, 2020 | Mar 31, 2020 |